These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3497717)

  • 1. Expression of a shared tumor-specific antigen by two chemically induced BALB/c sarcomas.
    Palladino MA; Srivastava PK; Oettgen HF; DeLeo AB
    Cancer Res; 1987 Oct; 47(19):5074-9. PubMed ID: 3497717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of a M(r) 110,000 tumor rejection antigen of the chemically induced BALB/c Meth A sarcoma.
    De Leo AB; Becker M; Lu L; Law LW
    Cancer Res; 1993 Apr; 53(7):1602-7. PubMed ID: 7680955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell surface antigens of chemically induced sarcomas of murine origin.
    DeLeo AB; Srivastava PK
    Cancer Surv; 1985; 4(1):21-34. PubMed ID: 3022922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants.
    Livingston PO; Jones M; Deleo AB; Oettgen HF; Old LJ
    J Immunol; 1985 Aug; 135(2):1505-9. PubMed ID: 4008930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of cloned class I MHC-restricted, CD8+ anti-Meth A cytotoxic T-lymphocytes: recognition of an epitope derived from the Meth A gp110 tumor rejection antigen.
    Fassanito MA; Loftus D; De Leo RM; Law LW; Appella E; De Leo AB
    Cancer Res; 1994 Aug; 54(16):4424-9. PubMed ID: 7519121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte.
    Frassanito MA; Mayordomo JI; DeLeo RM; Storkus WJ; Lotze MT; DeLeo AB
    Cancer Res; 1995 Jan; 55(1):124-8. PubMed ID: 7528638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor rejection antigens of the chemically induced BALB/c Meth A sarcoma.
    DeLeo AB
    Immunol Ser; 1994; 61():31-6. PubMed ID: 8011753
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
    Coggin JH
    Mol Biother; 1989; 1(4):223-8. PubMed ID: 2818874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of approaches for augmenting the serologic response to the individually specific methylcholanthrene-induced sarcoma-Meth A: pretreatment with cyclophosphamide is most effective.
    Livingston PO; DeLeo AB; Jones M; Oettgen HF
    J Immunol; 1983 Nov; 131(5):2601-5. PubMed ID: 6631013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical evidence of a tumor-specific surface antigen obtained by detergent solubilization of the membranes of a chemically induced sarcoma, meth-A.
    Natori T; Law LW; Appella E
    Cancer Res; 1978 Feb; 38(2):359-64. PubMed ID: 340027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common tumor-associated antigens of chemically induced mouse sarcomas expressing murine leukemia virus antigens by primary in vitro sensitization.
    Saito T
    Fukuoka Igaku Zasshi; 1984 Mar; 75(3):137-48. PubMed ID: 6088376
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors affecting passive monoclonal antibody therapy of Moloney sarcoma in BALB/c mice.
    Kennel SJ; Lankford PK; Flynn KM; Winegar R
    Cancer Res; 1985 Aug; 45(8):3782-9. PubMed ID: 2410101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
    Henderson LA; Ciavarra R; Riblet R; Forman J
    J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor rejection antigens of chemically induced sarcomas of inbred mice.
    Srivastava PK; DeLeo AB; Old LJ
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3407-11. PubMed ID: 3458189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
    Kono K; Petersson M; Ciupitu AM; Wen T; Klein G; Kiessling R
    Cancer Res; 1995 Dec; 55(23):5648-55. PubMed ID: 7585649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
    Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB
    Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to murine leukemia virus gp70 and p15(E) in sera of BALB/c mice immunized with syngeneic chemically induced sarcomas.
    Klitzman JM; Brown JP; Hellström KE; Hellström I
    J Immunol; 1980 Jun; 124(6):2552-6. PubMed ID: 6246166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological demonstration of an allogeneic Ia.7 antigen on the cell surface of SJL/J-derived reticulum cell sarcomas.
    Wilbur SM; Marelli O; Bonavida B
    Cancer Res; 1983 Sep; 43(9):4266-70. PubMed ID: 6347368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.